Cedar Mountain Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
Cedar Mountain Advisors's FBT Position: Q3 2026 in Review
Cedar Mountain Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 90 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #264.
Cedar Mountain Advisors first reported a position in FBT in Q4 2019 and has held it in 28 quarters since. The position peaked at $42K in Q2 2021. 88 funds tracked by Wall St. Rank hold FBT as of Q3 2026.
- Cedar Mountain Advisors held 90 shares of First Trust NYSE Arca Biotechnology Index Fund worth $24.5K as of Q3 2026.
- Cedar Mountain Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #264 holding.
- Cedar Mountain Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 28 quarters since.
- Cedar Mountain Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $42K in Q2 2021.
- 88 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.
Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.